Clinical trials
Pulmonary Disease, Chronic Obstructive (COPD) clinical trials
Below are recruiting pulmonary disease, chronic obstructive (copd) clinical trials, each written for real people, not researchers. We’re tracking 299 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07793409RecruitingPhase 3
Long-term safety study of lunsekimig for COPD
This study is a long-term follow-up for people with COPD who have already completed an earlier lunsekimig study. It aims to check the safety and effectiveness of the treatment over a longer period.
Newport Beach, CaliforniaAges 40–80 - NCT07780656RecruitingPhase 3
Felcorekibart for chronic obstructive pulmonary disease (COPD)
This study tests a new medicine, felcorekibart, to see if it can reduce COPD flare-ups better than a placebo after 52 weeks. It's designed for people with high eosinophils, a type of white blood cell linked to inflammation.
Miami, FloridaAges 40–80 - NCT07780669RecruitingPhase 3
Study of a new drug for moderate to severe COPD in smokers
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
Doral, FloridaAges 40–80 - NCT07777445Recruiting
Oxygen treatment during exercise for lung and pulmonary vascular disease
This study compares breathing normal air versus low-flow liquid oxygen during exercise to see if oxygen helps improve performance in people with conditions affecting the lungs or the blood vessels in the lungs. You would exercise while using a portable oxygen device and then without it to compare the effects.
Zurich, Canton of ZurichAges 18 years+ - NCT07777367Recruiting
Exercise with liquid oxygen in chronic lung disease
This study compares how well people with chronic lung diseases perform during exercise when breathing regular air versus when using low-flow liquid oxygen. It aims to see if using liquid oxygen during exercise can improve exercise ability and quality of life.
Zurich, Canton of ZurichAges 18 years+ - NCT07759245RecruitingPhase 2
Brenipatide for moderate-to-severe COPD
This trial tests a new medicine called Brenipatide to see if it can help people with moderate-to-severe COPD who still have symptoms despite using standard inhalers. The study will compare the effects of Brenipatide against a placebo to understand if it is safe and effective.
Birmingham, AlabamaAges 40–75 - NCT07762573Recruiting
Predicting COPD progression with dynamic chest x-rays
This study looks at whether a special type of chest x-ray (called dynamic chest radiography) can help predict how chronic obstructive pulmonary disease (COPD) might progress. It may help doctors better understand the disease and plan treatment.
Guangzhou, GuangdongAges 30–85 - NCT07762157Recruiting
Home-based exercise program for lung recovery after COPD flare-ups
This study tests whether a supervised home-based exercise program, delivered via video calls, can help people recovering from a COPD flare-up feel stronger and breathe easier, compared with usual care. If you join, you'll have regular online sessions with a rehab team from home.
Hong KongAges 18 years+ - NCT07750821Recruiting
Balance training for people with COPD
This study looks at whether adding balance training after standard pulmonary rehabilitation helps people with COPD improve their balance and reduce the risk of falls. It may help you feel more steady and confident in daily activities.
MiddlesbroughAges Any age - NCT07751705Recruiting
Using sound waves to collect lung mucus samples in COPD patients
This trial is testing whether a device that uses sound waves can help collect lung mucus samples more easily in people with COPD. It compares two groups: current smokers and ex-smokers, to see if the device works differently for them.
Hanover, Lower SaxonyAges 40 years+ - NCT07748858Recruiting
Heart care support for older African American patients
This study aims to improve care for older African American patients with heart conditions and other health problems. It tests ways to provide more patient-centered support.
Birmingham, AlabamaAges 50–99 - NCT07743021Recruiting
Blood sample study for better health screening
This study collects blood samples and health information over time to improve early detection of diseases. It may help researchers find ways to prevent serious conditions.
BalatonfüredAges 40 years+ - NCT07725939RecruitingPhase 2
Study of Galvokimig for moderate-to-severe COPD with chronic bronchitis
This study tests an experimental drug called Galvokimig (taken as a pill) to see if it can reduce COPD flare-ups and improve lung function in people with moderate to severe COPD and chronic bronchitis. It is for those who have had recent flare-ups and are already using maintenance inhalers.
Miami, FloridaAges 40–80 - NCT07719231Recruiting
Understanding body signals during COPD flare-ups
This study explores how people with COPD perceive body signals during a sudden worsening of symptoms (exacerbation) that requires a hospital stay. It aims to improve symptom management and patient care.
IstanbulAges 40–75 - NCT07714252Enrolling by invitation
Virtual palliative care team for veterans with heart or lung disease
This study tests a virtual team of nurses and social workers who provide palliative care to veterans with heart failure, COPD, or interstitial lung disease. The goal is to improve quality of life by offering extra support at home.
Phoenix, ArizonaAges 18 years+ - NCT07707271Recruiting
Continuous vs. interval exercise for COPD
This trial compares two types of exercise training—steady moderate exercise versus short bursts of higher intensity—to see which is more helpful for people with COPD. It aims to find a better way to improve your breathing and fitness.
Thessaloniki, ExohiAges Any age - NCT07707245Recruiting
Finding biomarkers in lung disease and lung cancer
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Milan, MilanAges 18 years+ - NCT07704567Recruiting
Using MoblO2 to maintain oxygen levels during activity
This study tests a device called MoblO2 to help people with COPD or interstitial lung disease keep their oxygen levels up during activity. If you normally use oxygen when you walk or exert yourself, this might help you stay active more safely.
Denver, ColoradoAges 25–95 - NCT07684820RecruitingPhase 2
A study of ExPD-101 for COPD with chronic bronchitis and frequent flare-ups
This study tests an experimental drug (ExPD-101) given daily as a pill for 52 weeks for people with COPD who have chronic bronchitis and frequent flare-ups. It compares the drug to a placebo (inactive pill) to see if it reduces flare-ups and improves symptoms.
Phoenix, ArizonaAges 40–85 - NCT07666841Recruiting
Home-based pulmonary rehab for chronic lung disease
This study tests whether a home-based pulmonary rehabilitation program using a smartphone or computer works as well as in-person rehab for people with chronic lung diseases like COPD or lung scarring. It aims to help you breathe better and feel stronger from home.
AshkelonAges 18 years+ - NCT07666854Recruiting
Home-based vs. in-person lung rehab for COPD patients in remote areas
This study compares remote (tele-pulmonary) rehab to in-person rehab for people with moderate-to-severe COPD who live far from medical centers. You join from home using a phone or computer, with guided exercises and support.
Tel AvivAges 40 years+ - NCT07668518RecruitingPhase 1/Phase 2
Study of KIT2014 for moderate to severe COPD
This trial tests a new medicine called KIT2014 in people with moderate to severe COPD. It aims to see if the drug is safe, tolerable, and helps improve breathing and COPD symptoms.
Charlestown, New South WalesAges 40–80 - NCT07665931Recruiting
Testing Simeox for severe COPD with lung hyperinflation
This trial tests if a device called Simeox can reduce trapped air in the lungs of people with severe COPD. It may help you breathe easier if you have pulmonary hyperinflation.
Codogno, LombardyAges 18 years+ - NCT07646587RecruitingPhase 2
Safety Study of WIN378 for Moderate-Severe COPD
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
Los Angeles, CaliforniaAges 40–80
Hear when a new Pulmonary Disease, Chronic Obstructive (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary disease, chronic obstructive (copd)?
- Yes. Clin2 currently lists 299 recruiting pulmonary disease, chronic obstructive (copd) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary disease, chronic obstructive (copd) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary disease, chronic obstructive (copd) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.